Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Are study dropouts different from completers?
Hypochondriacal concerns in depressed outpatients.
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder.
Income and attrition in the treatment of depression: a STAR*D report.
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.
Cognitive behavioral therapy for rapid-cycling bipolar disorder: a pilot study.
Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.
Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.